Medicine
Volume 38, Issue 2 , Pages 93-96, February 2010

Medium vessel vasculitis

Peter Hewins PhD MRCP is Consultant Nephrologist in the Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge, UK. Competing interests: none declared

David Jayne MD FRCP is Head of Vasculitis and SLE Services, Addenbrooke's Hospital, and Associate Lecturer in Renal Medicine, University of Cambridge, Cambridge, UK. Competing interests: none declared

Abstract 

Polyarteritis nodosa (PAN) and Kawasaki disease are primary systemic vasculitides with predominant medium-sized vessel involvement. PAN typically affects muscular arteries causing aneurysms (nodosa) detectable on angiography. There are no specific serological markers and diagnosis depends on clinical presentation, angiography and tissue biopsy. Treatment with corticosteroid and immunosuppressive drugs is usually effective but PAN can pursue a relapsing course. Kawasaki disease affects children, usually under the age of 5 years, and presents as an acute, febrile exanthematous disease. Inflammation and damage of muscular arteries particularly affect the coronary arteries leading to aneurysm formation. Prompt diagnosis and treatment with aspirin and intravenous immunoglobulin have reduced the frequency of this complication. Relapse is rare although vascular damage results in an increased risk of cardiovascular disease later in life. Medium-sized vessels can also be involved in organ-limited vasculitis affecting the skin (cutaneous polyarteritis), gut or brain. Additionally, medium-sized vessels can be involved in vasculitic syndromes defined by the predominant involvement of microscopic or large vessels.

Keywords: aneurysm, glucocorticoids, IVIg, immunosuppression, Kawasaki disease, polyarteritis nodosa, systemic vasculitis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1357-3039(09)00303-X

doi:10.1016/j.mpmed.2009.10.010

Medicine
Volume 38, Issue 2 , Pages 93-96, February 2010